Anupam Rasayan India Limited , a leading custom synthesis and specialty chemical player, has announced significant expansions in its long-term contracts and reported robust financial results for the first quarter of fiscal year 2026.

Contract Expansions and Sustainable Growth

The company has successfully expanded its long-term contracts with global leaders in the agrochemical and specialty chemical sectors. This strategic move aligns with Anupam Rasayan's commitment to sustainable growth and strengthening its position in the global market.

As part of its growth strategy, the company is incorporating value-added molecules into its operations. This initiative is expected to enhance its product portfolio and cater to the evolving needs of its global clientele.

Anupam Rasayan is also making substantial investments in eco-friendly processes, underscoring its dedication to sustainable practices in the chemical industry. These investments are likely to improve the company's environmental footprint while meeting the increasing demand for environmentally responsible chemical solutions.

Strong Financial Performance in Q1 FY26

The company's financial results for the quarter ended June 30, 2025, reflect significant growth:

• Consolidated total revenue stood at ₹4,907.00 million, marking an impressive year-on-year growth of 89%.
• EBITDA (including other income) reached ₹1,292.00 million, up by 118% compared to the same quarter last year.
• Profit After Tax (PAT) surged to ₹485.00 million, representing a substantial increase of 297% year-on-year.

Key Financial Highlights

The EBITDA margin for Q1 FY26 stood at an impressive 26%, indicating strong operational efficiency.

Management Commentary

Mr. Anand Desai, Managing Director of Anupam Rasayan, commented on the performance: "We strongly believe that the sectoral trends are in our favor, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan."

He further added, "During Q1 FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at ₹14,646.00 crore, reflecting the strong growth momentum in our business."

Business Expansion and Future Outlook

Anupam Rasayan has added one new product in Q1 FY26, taking its total product count to 80. The company's diverse product portfolio caters to various sectors, including agrochemicals, personal care, and pharmaceuticals.

The company's order book of ₹14,646.00 crore demonstrates strong future growth potential and reflects the confidence of global clients in Anupam Rasayan's capabilities.

As Anupam Rasayan continues to expand its long-term contracts, invest in eco-friendly processes, and deliver strong financial results, it is well-positioned to capitalize on the growing demand for specialty chemicals in both domestic and international markets.

Anupam Rasayan India Limited , a leading custom synthesis and specialty chemical player, has announced strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

• Revenue Surge: The company's consolidated total revenue for Q1 FY26 stood at ₹4,907.00 million, marking a substantial 89% year-on-year increase from ₹2,603.00 million in Q1 FY25.
• EBITDA Growth: EBITDA (including other income) reached ₹1,292.00 million, up by 118% compared to ₹592.00 million in the same quarter last year. The EBITDA margin improved to 26% from 23% in Q1 FY25.
• Profit After Tax: The company reported a consolidated net profit of ₹485.00 million, a remarkable 297% increase from ₹122.00 million in Q1 FY25.

Operational Performance

Anand Desai, Managing Director of Anupam Rasayan, commented on the company's performance: "We strongly believe that the sectoral trends are in our favor, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in the Agrochemical segment."

Market Expansion and Order Book

• Export Growth: Total exports accounted for 58% of the total revenue from operations during Q1 FY26.
• Strong Order Book: With two new agreements signed with Japanese and US-based multinational companies, Anupam Rasayan's order book now stands at an impressive ₹14,646.00 crore.

Segment Performance

The company reported strong performance across its business segments:

• Life Science Related Specialty Chemicals: This segment includes products related to Agrochemicals, Personal Care, and Pharmaceuticals.
• Performance Materials: This segment includes Polymer Additives.

Strategic Developments

• Product Portfolio Expansion: The company added one new product in Q1 FY26, taking the total to 80 products.
• R&D Focus: Anupam Rasayan maintains a strong R&D team of 90+ professionals, with 65+ molecules in R&D and pilot stages for pharma and polymer segments.

Outlook

The management expressed confidence in the company's growth trajectory, citing favorable sectoral trends and encouraging performance in key markets like the USA and Japan. The robust order book of ₹14,646.00 crore reflects strong growth momentum for the business.

Anupam Rasayan's strong Q1 FY26 performance underscores its position as a key player in the specialty chemicals sector, with a clear focus on custom synthesis and manufacturing. The company's strategic initiatives and diverse product portfolio are well-positioned to capitalize on growing market opportunities in the coming quarters.

Note: All financial figures are in Indian Rupees (₹).